Published in J Physiol Pharmacol on December 01, 2009
Enhanced wound healing by recombinant Escherichia coli Nissle 1917 via human epidermal growth factor receptor in human intestinal epithelial cells: therapeutic implication using recombinant probiotics. Infect Immun (2011) 0.85
Modulation of PPAR-γ by Nutraceutics as Complementary Treatment for Obesity-Related Disorders and Inflammatory Diseases. PPAR Res (2012) 0.83
Mechanisms by which Stress Affects the Experimental and Clinical Inflammatory Bowel Disease (IBD): Role of Brain-Gut Axis. Curr Neuropharmacol (2016) 0.80
Interaction of Lactobacillus fermentum BGHI14 with rat colonic mucosa: implications for colitis induction. Appl Environ Microbiol (2013) 0.80
Potential role of probiotics in the management of gastric ulcer. Exp Ther Med (2016) 0.79
Inhibition of acid secretion in dog by metiamide, a histamine antagonist acting on H2 receptors. Gastroenterology (1974) 2.87
Trophic action of epidermal growth factor on the pancreas and gastroduodenal mucosa in rats. J Physiol (1982) 1.80
Effect of growth hormone release-inhibiting hormone on gastric secretion, mucosal blood flow, and serum gastrin. Gastroenterology (1976) 1.74
Studies on the gastroprotective and ulcer-healing effects of colloidal bismuth subcitrate. Digestion (1987) 1.69
Role of epidermal growth factor in healing of chronic gastroduodenal ulcers in rats. Gastroenterology (1988) 1.65
Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. J Physiol Pharmacol (2011) 1.62
Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty. Dig Liver Dis (2001) 1.59
Effects of reactive oxygen species action on gastric mucosa in various models of mucosal injury. J Physiol Pharmacol (2002) 1.55
Gastric cytoprotection by epidermal growth factor. Role of endogenous prostaglandins and DNA synthesis. Gastroenterology (1981) 1.52
Proof of a pyloro-oxyntic reflex for stimulation of acid secretion. Gastroenterology (1974) 1.51
Effect of glucagon on meal-induced gastric secretion in man. Gastroenterology (1975) 1.49
Role of prostaglandins in the formation of aspirin-induced gastric ulcers. Gastroenterology (1981) 1.40
Effect of metiamide, a histamine H2-receptor antagonist, on gastric response to histamine, pentagastrin, insulin, and peptone meal in man. Am J Dig Dis (1974) 1.32
Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol (2004) 1.32
Helicobacter pylori infection in gastric cancerogenesis. J Physiol Pharmacol (2009) 1.31
Effect of atropine on gastric acid response to graded doses of pentagastrin and histamine in duodenal ulcer patients before and after vagotomy. Am J Dig Dis (1968) 1.28
Effect of medical and surgical vagotomy on gastric response to graded doses of pentagastrin and histamine. Gastroenterology (1968) 1.28
Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers. Eur J Pharmacol (1993) 1.25
Distribution and release of epidermal growth factor in man. Gut (1989) 1.25
Vagal cholinergic control of gastric alkaline secretion in normal subjects and duodenal ulcer patients. Gut (1987) 1.24
Helicobacter pylori-gastrin link in MALT lymphoma. Aliment Pharmacol Ther (2000) 1.23
Effect of extragastric and truncal vagotomy on pancreatic secretion in the dog. Am J Physiol (1975) 1.23
Cephalic phase of gastric secretion in healthy subjects and duodenal ulcer patients: role of vagal innervation. Gut (1979) 1.22
Effect of growth hormone-release inhibiting hormone on hormones stimulating exocrine pancreatic secretion. J Clin Invest (1976) 1.22
Gastric cytoprotection. Scand J Gastroenterol (1985) 1.21
Role of mucosal prostaglandins and DNA synthesis in gastric cytoprotection by luminal epidermal growth factor. Gut (1981) 1.21
Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans. Gastroenterology (1998) 1.20
Comparison of vasoactive intestinal peptide and secretin in stimulation of pancreatic secretion. J Physiol (1976) 1.19
Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage. Regul Pept (2004) 1.18
Role of oxidative stress in the pathogenesis of caerulein-induced acute pancreatitis. Eur J Pharmacol (1999) 1.18
Comparison of amino acids bathing the oxyntic gland area in the stimulation of gastric secretion. Gastroenterology (1976) 1.18
The effect of secretin on gastric acid secretion and peptic ulcers induced by pentagastrin in cats with intact or resected duodenum. Am J Dig Dis (1968) 1.17
Gut clock: implication of circadian rhythms in the gastrointestinal tract. J Physiol Pharmacol (2011) 1.16
Helicobacter pylori and gastric adaptation to repeated aspirin administration in humans. J Physiol Pharmacol (1997) 1.15
Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischemia-reperfusion-induced gastric lesions. Eur J Pharmacol (1999) 1.14
Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome. J Physiol Pharmacol (2007) 1.14
Role of locally generated prostaglandins in adaptive gastric cytoprotection. Dig Dis Sci (1982) 1.12
Effect of metiamide, a histamine H2-receptor antagonist, on mucosal blood flow and serum gastrin level. Gastroenterology (1974) 1.12
The effect of cholinergic and adrenergic blockage on basal and pentagastrin-induced acid secretion. Scand J Gastroenterol (1969) 1.12
Ghrelin attenuates the development of acute pancreatitis in rat. J Physiol Pharmacol (2003) 1.11
Endogenous nitric oxide in the control of esophageal motility in humans. J Physiol Pharmacol (1997) 1.10
Helicobacter pylori induces apoptosis in gastric mucosa through an upregulation of Bax expression in humans. Scand J Gastroenterol (1999) 1.10
Effect of vagotomy on hormones stimulating pancreatic secretion. Arch Surg (1974) 1.09
Transforming growth factor alpha and epidermal growth factor in protection and healing of gastric mucosal injury. Scand J Gastroenterol (1992) 1.09
Epidermal growth factor in protection, repair, and healing of gastroduodenal mucosa. J Clin Gastroenterol (1991) 1.09
Apoptosis in gastric mucosa with stress-induced gastric ulcers. J Physiol Pharmacol (1999) 1.08
Effect of exclusion, acidification, and excision of the duodenum on gastric acid secretion and the production of pentagastrin-induced peptic ulcers in cats. Gastroenterology (1969) 1.08
Gastrin-like pentapeptide I.C.I. 50 123: a potent gastric stimulant in man. Am J Dig Dis (1967) 1.08
Gastrocytoprotection by colloidal bismuth subcitrate (De-Nol) and sucralfate. Role of endogenous prostaglandins. Gut (1987) 1.08
Ghrelin-a new gastroprotective factor in gastric mucosa. J Physiol Pharmacol (2004) 1.07
Role of melatonin in upper gastrointestinal tract. J Physiol Pharmacol (2007) 1.07
Effect of calcium and calcitonin on gastrin and gastric secretion in cats. Am J Physiol (1973) 1.07
Effects of epidermal growth factor on gastrointestinal secretions. Am J Physiol (1984) 1.05
Bicarbonate and cyclic AMP content of pure human pancreatic juice in response to graded doses of synthetic secretin. Gastroenterology (1976) 1.05
Advances in the understanding of the mechanism of cytoprotective action by colloidal bismuth subcitrate. Scand J Gastroenterol Suppl (1986) 1.04
Helicobacter pylori, gastrin and cyclooxygenase-2 in lung cancer. Med Sci Monit (2001) 1.03
Expression of survivin and caspase-3 in gastric cancer. Dig Dis Sci (2003) 1.03
Effect of glucagon on gastric and pancreatic secretion and peptic ulcer formation in cats. Am J Dig Dis (1974) 1.03
Influence of gastrin on the expression of cyclooxygenase-2, hepatocyte growth factor and apoptosis-related proteins in gastric epithelial cells. J Physiol Pharmacol (2003) 1.03
Comparison of secretin and vasoactive intestinal peptide on pancreatic secretion in dogs. Gastroenterology (1975) 1.03
Ghrelin ameliorates colonic inflammation. Role of nitric oxide and sensory nerves. J Physiol Pharmacol (2009) 1.02
Gastroprotective effects of flavonoids in plant extracts. J Physiol Pharmacol (2005) 1.02
Comparison of methionine-enkephalin and morphine in the stimulation of gastric acid secretion in the dog. Gastroenterology (1980) 1.02
Association of the presence of Helicobacter pylori in the oral cavity and in the stomach. J Physiol Pharmacol (2004) 1.02
Role of epidermal growth factor, prostaglandin, and sulfhydryls in stress-induced gastric lesions. Gastroenterology (1990) 1.02
Role of gastric acid secretion in progression of acute gastric erosions induced by ischemia-reperfusion into gastric ulcers. Eur J Pharmacol (2000) 1.02
Melatonin and aging: prospects for human treatment. J Physiol Pharmacol (2011) 1.01
Gastric acid does drive pancreatic bicarbonate secretion. Scand J Gastroenterol (1974) 1.01
Neuro-hormonal control of food intake: basic mechanisms and clinical implications. J Physiol Pharmacol (2005) 1.01
Gastric secretory and plasma hormonal responses to sham-feeding of varying duration in patients with duodenal ulcer. Gut (1981) 1.01
Prostaglandins as mediators of COX-2 derived carcinogenesis in gastrointestinal tract. J Physiol Pharmacol (2005) 1.01
Comparison of methylated prostaglandin E2 analogues given orally in the inhibition of gastric responses to pentagastrin and peptone meal in man. Gastroenterology (1976) 1.00
Purification and properties of a bacterial carbamyl phosphate synthetase. J Biol Chem (1966) 1.00
Prostaglandins and alkaline secretion from oxyntic, antral, and duodenal mucosa of the dog. Am J Physiol (1983) 1.00
Gastric cancer and Helicobacter pylori infection. J Physiol Pharmacol (2006) 1.00
Effects of nicotine on gastrointestinal secretions.. Gastroenterology (1971) 1.00